Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
2023年11月9日 - 6:05AM
Invizyne Technologies, Inc., a leading designer of
enzyme-based biomanufacturing systems – and a subsidiary
of
MDB Capital Holdings, LLC,
(NASDAQ:MDBH) ("MDB") – today announced the
appointment of Michael Burns to its senior leadership team as
Executive Vice President, Energy Transition.
"Michael Burns brings two decades worth of business strategy and
development, global licensing, project development, and project
finance expertise in the sustainable energy and synthetic biology
industries to Invizyne. We are honored to have an executive with
his gravitas and experience join the team to head up our new Energy
Transition business unit,” said Mo Hayat, CEO of Invizyne.
Prior to joining Invizyne, Mr. Burns served as the Head of
Bio-Refining in the Americas for Novozymes, the global leader in
industrial enzymes, where he focused on the expansion of
second-generation biomass conversion technologies and the
transition to next generation fuels and chemicals. Prior to
Novozymes, he held leadership roles in BP’s Advanced Bio-Products
unit. He also served in strategy and development roles at Verenium
Corporation, a specialized enzyme biotechnology company that was
acquired by BASF.
In his new position, Mr. Burns will lead Invizyne’s Energy
Transition business unit, which was created as a result of key
breakthroughs enabled by the company’s cell-free enzyme technology
platform, SimplePath™, that was featured in the peer-reviewed,
scientific journal, Nature Communications (“Isobutanol production
freed from biological limits using synthetic biochemistry”).
Invizyne’s continued advancements of the isobutanol version of
SimplePath™ recently led to a follow-on grant of $3.77 million from
the Bioenergy Technologies Office within the U.S. Department of
Energy. The additional funds and new business unit will initially
focus on optimizing and scaling-up isobutanol production to address
the potential $27.4 billion sustainable aviation fuel market.
"The need for sustainable and carbon reduction technologies has
never been more critical to our planet and I am thankful for the
brilliant team of scientists and technologists at Invizyne that
developed this disruptive biomanufacturing 2.0 platform to address
these needs,” said Mr. Burns. “After serving in a variety of
leadership roles at both startups and global strategics, I am
excited to leverage my unique experience and perspective to help
accelerate our path to commercialization in the energy transition
space,” said Mr. Burns.
Mr. Burns received a B.A. from Bryant University and an MBA from
Western New England College. In 2019, he was elected to the Board
of the Low Carbon Fuels Coalition, a technology neutral trade
association with a proven track record of supporting and expanding
clean fuel standards, where he held executive positions from 2020
until September 2023.
About Invizyne Technologies, Inc. Invizyne, a
subsidiary of MDB Capital Holdings, LLC,
(NASDAQ:MDBH) ("MDB") (www.mdb.com), is an enzyme-based
biomanufacturing technology company headquartered in Monrovia,
California. The company specializes in designing enzymes and
building truly cell-free enzymatic pathways that can run
continuously and unassisted outside of living cells, therefore
avoiding many of the problems other synthetic biology companies run
into when trying to scale cell-based or immobilized
biomanufacturing technologies. With a vision to enable a new
generation of natural resources, we believe Invizyne's enzyme
design capabilities, coupled with its patent protected
biomanufacturing technology platform, position the company to drive
positive change in the biofuels industry and many other industries
that are looking for greener and better manufacturing
technologies.
For more information, please
visit www.invizyne.com
Media contacts: press@invizyne.com Partnership
contacts: partners@invizyne.com
Forward-Looking StatementsThis press release contains
"forward-looking statements." These forward-looking statements are
made as of the date they were first issued and were based on
current expectations, estimates, forecasts and projections as well
as the beliefs and assumptions of management. Words such as
"expect," "anticipate," "should," "believe," "hope," "target,"
"project," "goals," "estimate," "potential," "predict," "may,"
"will," "might," "could," "intend," "shall" and variations of these
terms or the negative of these terms and similar expressions are
intended to identify these forward-looking statements.
Forward-looking statements are subject to a number of risks and
uncertainties, many of which involve factors or circumstances that
are beyond Invizyne's control. Invizyne's actual results could
differ materially from those stated or implied in forward-looking
statements due to a number of factors. The forward-looking
statements included in this press release represent Invizyne's
views as of the date of this press release. Invizyne anticipates
that subsequent events and developments will cause its views to
change. Invizyne undertakes no intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise. These forward-looking
statements should not be relied upon as representing Invizyne's
views as of any date subsequent to the date of this press
release.
MDB Capital (NASDAQ:MDBH)
過去 株価チャート
から 5 2024 まで 6 2024
MDB Capital (NASDAQ:MDBH)
過去 株価チャート
から 6 2023 まで 6 2024